Bone morphogenetic protein 2 (BMP2) and basic fibroblast growth factor (bFGF)
have been shown to exhibit a synergistic effect to promote bone repair and
healing. In this study, we constructed a novel adenovirus with high coexpression
of BMP2 and bFGF and evaluated its effect on osteogenic differentiation of goat
bone marrow progenitor cells (BMPCs). Recombinant adenovirus Ad-BMP2-bFGF was
constructed by using the T2A sequence. BMPCs were isolated from goats by density
gradient centrifugation and adherent cell culture, and were then infected with
Ad-BMP2-bFGF or Ad-BMP2. Expression of BMP2 and bFGF was detected by ELISA, and
alkaline phosphatase (ALP) activity was detected by an ALP assay kit. In
addition, von Kossa staining and immunocytochemical staining of collagen II were
performed on BMPCs 21 days after infection. There was a high coexpression of
BMP2 and bFGF in BMPCs infected with Ad-BMP2-bFGF. Twenty-one days after
infection, ALP activity was significantly higher in BMPCs infected with
Ad-BMP2-bFGF than in those infected with Ad-BMP2. Larger and more mineralized
calcium nodules, as well as stronger collagen II staining, were observed in
BMPCs infected with Ad-BMP2-bFGF than in those infected with Ad-BMP2. In
summary, we developed a novel adenovirus vector Ad-BMP2-bFGF for simultaneous
high coexpression of BMP2 and bFGF, which could induce BMPCs to differentiate
efficiently into osteoblasts.